Mariner
HCAT icon

Mariner’s Health Catalyst HCAT Stock Holding History

Mariner’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,476
Closed -$93.9K – 3221
2024
Q1 		$93.9K Sell
12,476
-194
-2% -$1.77K ﹤0.01% 2942
2023
Q4 		$117K Sell
12,670
-7,626
-38% -$62.3K ﹤0.01% 2824
2023
Q3 		$205K Sell
20,296
-1,132
-5% -$13.5K ﹤0.01% 2485
2023
Q2 		$268K Sell
21,428
-4,551
-18% -$54.2K ﹤0.01% 2220
2023
Q1 		$303K Sell
25,979
-734
-3% -$9.36K ﹤0.01% 2060
2022
Q4 		$284K Buy
26,713
+13,603
+104% +$131K ﹤0.01% 2073
2022
Q3 		$127K Buy
+13,110
New +$174K ﹤0.01% 2153

Other funds holding HCAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return